Free Trial

one8zero8 LLC Makes New Investment in Waters Co. (NYSE:WAT)

Waters logo with Medical background
Remove Ads

one8zero8 LLC purchased a new stake in shares of Waters Co. (NYSE:WAT - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 4,150 shares of the medical instruments supplier's stock, valued at approximately $1,540,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. Natixis Advisors LLC grew its stake in shares of Waters by 11.1% during the fourth quarter. Natixis Advisors LLC now owns 156,614 shares of the medical instruments supplier's stock worth $58,101,000 after buying an additional 15,622 shares during the last quarter. Catalyst Funds Management Pty Ltd bought a new stake in Waters during the 4th quarter worth $594,000. Aviso Financial Inc. increased its holdings in Waters by 20.9% in the 4th quarter. Aviso Financial Inc. now owns 5,451 shares of the medical instruments supplier's stock worth $2,022,000 after purchasing an additional 941 shares in the last quarter. LBP AM SA bought a new position in Waters in the fourth quarter valued at about $2,138,000. Finally, Madison Investment Advisors LLC acquired a new stake in shares of Waters during the fourth quarter valued at about $104,645,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Trading Down 1.2 %

Shares of NYSE:WAT traded down $4.67 during mid-day trading on Wednesday, hitting $377.48. The company had a trading volume of 47,396 shares, compared to its average volume of 435,776. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. Waters Co. has a one year low of $279.24 and a one year high of $423.56. The firm has a fifty day moving average price of $391.36 and a 200 day moving average price of $370.97. The company has a market capitalization of $22.43 billion, a PE ratio of 35.36, a price-to-earnings-growth ratio of 3.79 and a beta of 1.00.

Remove Ads

Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. As a group, research analysts forecast that Waters Co. will post 12.86 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on WAT shares. JPMorgan Chase & Co. raised their price objective on shares of Waters from $380.00 to $390.00 and gave the company a "neutral" rating in a report on Thursday, March 6th. Barclays raised shares of Waters from an "underweight" rating to an "equal weight" rating and raised their price target for the company from $360.00 to $415.00 in a research note on Monday, February 10th. Sanford C. Bernstein raised shares of Waters from a "market perform" rating to an "outperform" rating and set a $430.00 price objective on the stock in a research note on Friday, January 10th. UBS Group raised their target price on Waters from $405.00 to $410.00 and gave the stock a "neutral" rating in a research report on Thursday, February 13th. Finally, Wells Fargo & Company upped their price target on Waters from $415.00 to $420.00 and gave the company an "overweight" rating in a research report on Thursday, February 13th. Eleven investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $391.07.

Read Our Latest Stock Analysis on WAT

Waters Company Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Featured Articles

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Should You Invest $1,000 in Waters Right Now?

Before you consider Waters, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.

While Waters currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

SMCI’s Rally Isn’t Over – Here’s Why It Could Hit $100!
7 Flying Car Stocks to Buy Before the Sector Really Takes Off
Institutions Are Dumping These 3 Stocks—Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads